| Wednesday, 31 May 2006: 2:00 PM-5:30 PM | |||
| Regency Ballroom A (Hyatt Regency Milwaukee) | |||
| Medicinal Chemistry (MEDI) | |||
| New Strategies for Modern Medicinal Chemistry II | |||
| Organizer: | Keith McDaniel | ||
| Presider: | Mark Cushman | ||
| 2:00 PM | 72 | Targeting heterodimeric G protein-coupled receptors as an added dimension in drug design. Opioid receptors as proof of concept Philip S. Portoghese | |
| 2:45 PM | 73 | Targeting protein-protein interactions for the treatment of cancer: discovery of Bcl-2 family protein inhibitors Steven W. Elmore | |
| 3:30 PM | Break | ||
| 4:00 PM | 74 | Design of Potent and Selective 2-Aminobenzimidazole-Based p38 MAP Kinase Inhibitors with Excellent in Vivo Efficacy Mary M. Mader | |
| 4:45 PM | 75 | NO New Strategies in Modern Medicinal Chemistry: Nitrates and NO (Nitric Oxide) Chimeras Gregory R. J. Thatcher, Ghenet K Hagos, Samer Abdul-Hay, Ramy E Abdelhamid, Min Li, Irida Kastrati, Zhiqiang Wang, Qian Li | |
Back to The 37th Great Lakes Regional Meeting (May 31- June 2, 2006)